ADVERTISEMENT
Opinion: Emergency Use Authorizations Are a Threat to Science<strong>&nbsp;</strong>
Opinion: Emergency Use Authorizations Are a Threat to Science 
As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.
Opinion: Emergency Use Authorizations Are a Threat to Science 
Opinion: Emergency Use Authorizations Are a Threat to Science 

As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.

As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.

disease & medicine, opinion

Opinion: Scientists in the US and China Collaborating on COVID-19
Jenny J. Lee and John P. Haupt | Jun 22, 2020 | 4 min read
Despite high-profile political tensions between the two countries, researchers in the US and China are working together now more than ever, according to our bibliometric study.
covid-19 coronavirus pandemic vaccine cholera sars-cov-2 vaccination strategy thailand
Opinion: Look to Cholera Vaccine Campaigns for COVID-19 Guidance
Joshua Havumaki | Jun 15, 2020 | 4 min read
Accounting for a limited stockpile of cholera vaccine can provide insight into the most effective way to distribute future COVID-19 vaccines.
Opinion: Ethically Accessing Experimental Therapies for COVID-19
John D. Loike and Jennifer E. Miller | Apr 8, 2020 | 4 min read
In the midst of a pandemic, individual patients are not always the focus of the ethics discussions.
coronavirus covid-19 sars-cov-2 economic patents shared open access research vaccine development
Opinion: Stop Private Speculation in COVID-19 Research
Emiliano Brancaccio and Ugo Pagano | Mar 23, 2020 | 3 min read
We present an economic plan for a collective sharing of scientific knowledge on the pandemic.
medicare for all veterans affairs single payer healthcare insurance
Opinion: Health Reform in America—Where Are the Scientists?
Rachel Madley | Dec 31, 2019 | 4 min read
Medicare for All could expand access to medical interventions—the very goal of biomedical research.
antibiotics antibiotics resistance persister bacteria bacteriophage
Opinion: We Need More than New Antibiotics to Fight Resistance
Neil S. Greenspan and Arturo Casadevall | Nov 1, 2019 | 3 min read
Metabolic disrupters, phages, and other approaches are going to be needed to treat the broadest possible range of patients infected by bacterial pathogens resistant to multiple drugs.
Opinion: Learning from Immunotherapy’s Recent Failures
Luis Felipe Campesato | Aug 1, 2018 | 6 min read
The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.
Opinion: No, AI Will Not Replace Radiologists
Phil Shaffer | Jul 17, 2018 | 4 min read
The adoption of machine-learning techniques to aid in diagnosis should be done with radiologists’ guidance.
Opinion: Rise of the Robot Radiologists
Mutaz Musa | Jun 25, 2018 | 4 min read
The first wave of AI-driven job loss among doctors will be in the field of radiology and is poised to force a paradigm shift in medical imaging.
ADVERTISEMENT